BROMOCRIPTINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Bromocriptine, and when can generic versions of Bromocriptine launch?
Bromocriptine is a drug marketed by Lek Pharm, Mylan, Zydus Pharms Usa Inc, Aurobindo Pharma Usa, Padagis Us, and Sandoz. and is included in six NDAs.
The generic ingredient in BROMOCRIPTINE is bromocriptine mesylate. There are nine drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the bromocriptine mesylate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Bromocriptine
A generic version of BROMOCRIPTINE was approved as bromocriptine mesylate by SANDOZ on January 13th, 1998.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for BROMOCRIPTINE?
- What are the global sales for BROMOCRIPTINE?
- What is Average Wholesale Price for BROMOCRIPTINE?
Summary for BROMOCRIPTINE
| US Patents: | 0 |
| Applicants: | 6 |
| NDAs: | 6 |
| Drug Prices: | Drug price information for BROMOCRIPTINE |
| DailyMed Link: | BROMOCRIPTINE at DailyMed |


